Skip to main content

ScholarsBetaWeill Cornell Medicine

Browse About Sign in

Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Loading search results…

Browse

Scholars8,800 Publications201,349 Funding7,267 Clinical research2

FiltersClear all

Status

Recruiting1
Completed1

Study type

Interventional2

Phase

Phase 22

Investigator

Anthony O. Ahmed1
Faith Gunning1

Department

Psychiatry2

Condition

Cognitive Dysfunction2
Atrial Fibrillation19
Heart Failure15
Stroke8
Cardiovascular Diseases7

Intervention type

Device2
Drug6
Behavioral4
Other2

Sponsor type

Industry1
WCM (investigator-initiated)1

Start date

to

Has results posted1

Cognitive Dysfunction×Device×Clear all

Showing 1–2 of 2 studiesSort:

RecruitingInterventional · Phase 2NCT06502964 ↗
Double-Blind, Placebo-Controlled Study of ALTO-101 in Patients With Schizophrenia and Cognitive Impairment

Show all 50

Show fewer

Anthony O. AhmedPI

Intervention: Drug: ALTO-101 · Device: ALTO-101 Transdermal Delivery System · Drug: Placebo · Device: Placebo Transdermal Delivery System
Dates: Jun 2024 – Feb 2026 (est.)
Sponsor: Alto Neuroscience

SchizophreniaCognitive Impairment

CompletedInterventional · Phase 2NCT04843930 ↗

Improving Cognitive Health in COVID-19 Survivors Through Digital Therapeutics

Faith GunningPI

Intervention: Device: AKL-T01
Dates: Jul 2021 – Feb 2023· Results posted
Sponsor: Weill Medical College of Cornell University

Cognitive DysfunctionCovid19